Emmett V Schmidt

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Clostridium Difficile

Randomized Controlled Trial

Irritable Bowel Syndrome

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Seminars in immunopathology

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo Marin, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, Matthew H Taylor
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2023)
Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo Marin, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, Matthew H Taylor
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2023)
Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo Marin, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, Matthew H Taylor
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo Marin, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, Matthew H Taylor
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2023)
Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo Marin, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, Matthew H Taylor
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2023)
Anna M Bruchez, Ky Sha, Joshua C Johnson, Li Chen, Caroline Stefani, Hannah McConnell, Lea Gaucherand, Rachel Prins, Kenneth A Matreyek, Adam J Hume, Elke Mühlberger, Emmett V Schmidt, Gene G Olinger, Lynda M Stuart, Adam Lacy-Hulbert
MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses. Science (New York, N.Y.) 370 (6513) (2020)
Emmett V Schmidt
Developing combination strategies using PD-1 checkpoint inhibitors to treat cancer. Seminars in immunopathology 41 (1) (2018)